NASDAQ:TRIB

Trinity Biotech Q1 2025 Earnings Results & Report

Trinity Biotech logo
$6.01 +0.63 (+11.71%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$5.71 -0.30 (-4.99%)
As of 07:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Trinity Biotech beat analyst earnings expectations but missed on revenue in its Q1 2025 results, released January 2, 2026. The company reported EPS of -$9.60 versus the -$44.40 consensus estimate, while revenue of $9.20 million fell short of the $10.50 million estimate by $1.30 million.

Earnings Announcement Details

Quarter
Q1 2025
Report Date
Time
Before Market Opens
Conference Call Date
Conference Call
7:30 AM ET

Trinity Biotech EPS Results

Actual EPS
-$9.60
Consensus EPS
-$44.40
Beat/Miss
Beat by +$34.80
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 5 quarters

Trinity Biotech Revenue Results

Actual Revenue
$9.20 million
Expected Revenue
$10.50 million
Beat/Miss
Missed by -$1.30 million
YoY Revenue Growth
N/A

Upcoming Earnings

Trinity Biotech's Q2 2026 earnings is estimated for Thursday, December 10, 2026, based on past reporting schedules

Conference Call Resources

Trinity Biotech Q1 2025 Earnings FAQ

Trinity Biotech (NASDAQ:TRIB) reported earnings of -$9.60 per share for Q1 2025, beating the consensus estimate of -$44.40. The report was announced on Friday, January 2, 2026.

Trinity Biotech reported revenue of $9.20 million for Q1 2025, against a consensus estimate of $10.50 million.

Trinity Biotech's next earnings date is estimated for Thursday, December 10, 2026. MarketBeat tracks confirmed and estimated earnings dates for Trinity Biotech on the company's earnings history page.

Trinity Biotech Earnings Headlines

My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
See More Trinity Biotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Trinity Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Trinity Biotech and other key companies, straight to your email.

About Trinity Biotech

Trinity Biotech (NASDAQ:TRIB) is an Irish diagnostics company that develops, manufactures and markets products for point-of-care testing and clinical laboratories. Its offerings include rapid tests for infectious diseases such as HIV, as well as laboratory assays used in areas including diabetes care.

The company also provides products for monitoring blood glucose and assessing long-term blood sugar control. Trinity Biotech serves customers in multiple international markets through a combination of direct sales and distribution partners.

View Trinity Biotech Profile